Sponsor Pipeline

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
6
Recruiting
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-11 NCT07758920 A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment… Phase 2 Recruiting
Active Trials by Phase
Phase 2
6
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07174115 A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of… Chronic Sinusitis Without Nasal Polyps Recruiting
NCT07147049 Evaluate the Safety and Efficacy of HL-1186 Tablet for Moderate to Severe Acute Pain… Moderate to Severe Acute Postoperative Pain Recruiting
NCT07311369 Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Pain Management in… Moderate to Severe Acute Postoperative Pain Recruiting
NCT07413094 Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDS Sepsis Recruiting
NCT07758920 A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment… Postherpetic Neuralgia ( PHN ) Recruiting
NCT07159243 Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral… Diabetic Peripheral Neuropathic Pain Not Yet Recruiting
Phase 1
NCT06912295 Assess the Safety, Tolerability, and Pharmacokinetics of HL-1186 in Healthy Participants Healthy Participants Recruiting
NCT07098091 Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of YD0293 in… Healthy Participants Enrolling by Invitation
Get alerts when Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free